Sorry for the long delay. There is still a possible good future for this company but the management seems to have reverted to the old EFSF ways of updating the shareholders.

For a while, as NVLX reached over .05, it looked like we could be on our way. We're back under .03 again with no update of the immediate goals such as -Last Shot- sales. We have to presume the sales are going worse than management most pessimistic views.

OraPhyte could eventually break some good news, but for now, i concur with your view entirely.

GLTY

go